Medicine and Dentistry
RNA 16S
100%
Drug Therapy
100%
Diabetes
100%
Gut Microbiome
100%
Maturity Onset Diabetes of the Young
66%
Gut
66%
Insulin Sensitivity
33%
Doctor of Philosophy
33%
Dysbiosis
33%
Caloric Intake
33%
Gut Microbiota
33%
Immune System
33%
Cardiovascular Disease
33%
Gene Expression
33%
RNA Sequence
33%
Peroxisome Proliferator Activated Receptor
33%
Amplicon
33%
Diabetes Mellitus
33%
Diet Induced Obesity
33%
Glucagon Like Peptide 1
33%
Bacterial DNA
33%
Glycemic Control
33%
Glucagon-Like Peptide-1 Agonist
33%
Fecal Microbiota Transplantation
33%
Glucagon Like Peptide 2 Receptor Agonist
33%
Peroxisome Proliferator Activated Receptor Agonist
33%
Gastrointestinal Tract
33%
Energy Metabolism
33%
Metabolite
33%
Copurification
33%
Liraglutide
33%
Immunology and Microbiology
Gut Microbiome
100%
Agonist
100%
Microorganism
66%
Mouse Model
66%
Peroxisome
66%
Metagenomics
33%
Immune System
33%
Energy Metabolism
33%
Metabolite
33%
Gene Expression
33%
Intestine Flora
33%
Gastrointestinal Tract
33%
Amplicon
33%
RNA Sequence
33%
Feces microflora
33%
Insulin Sensitivity
33%
Glycemic Control
33%
Comorbidity
33%
Keyphrases
GLP-2 Receptor
25%
Full-length 16S rRNA Sequencing
25%
Health Comorbidities
25%
Host mRNA
25%
Amplicon Metagenomics
25%
16S RNA Sequencing
25%
Intestinal Receptors
25%
Pharmacology, Toxicology and Pharmaceutical Science
Glucagon Like Peptide 2 Receptor Agonist
33%